ProfileGDS4459 / ENSG00000203804
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 30% 20% 39% 36% 44% 39% 40% 41% 41% 42% 42% 33% 48% 26% 40% 65% 39% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.7630
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.3920
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.9239
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.0436
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 54.1544
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 6439
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.0240
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 84.0141
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.0141
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.1142
GSM623474group B, liver allograft wedge biopsie placebo treatment 14.0142
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.6633
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.3448
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.6426
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.9540
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.9565
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.0239